Desperation masked by euphoria
Markets might continue to celebrate a smaller than expected economic contraction in the US, but across the Atlantic some once mighty nations are using dangerous levels of public debt to stay afloat.
Help for dieting fat-cats
Things have changed dramatically since the Productivity Commission's inquiry into executive remuneration began, with many exasperated directors keen to see the shopping-list demands of would-be executives cut down to size.
China's historical whitewash
As China celebrated the 'achievements' of 60 years of communist rule yesterday, how many of its people even knew that a large part of that period was blighted by economic mismanagement and brutal political suppression?
A High Court showdown for NSW
It appears the Picton farmer challenging the constitutionality of NSW's occupational health and safety laws has found some support at the High Court. That may be good news for Julia Gillard.
Beware salary-slashing contagion
Sweeping regulatory changes on executive remuneration will boost the shareholder democracy movement, but could mean a lower standard of CEOs and profits as Australia falls out of line with global trends.
Unfrozen, but unhealthy
While US credit markets have begun to thaw, the most recent update from Macquarie Fortress provides a very disconcerting window into the health of the real US economy.
Why the FIRB digs China
Patrick Colmer's comments are not a sign the Foreign Investment Review Board is racist towards China, but instead reflect the intensity of activity by their state-owned-enterprises.
The direct path to a safer workplace
Julia Gillard’s new OHS laws represent real progress towards stronger and more successful work safety laws – if the unions can be prevented from derailing them.
After a week of major developments, we've picked out commentary from Kohler on market euphoria and remuneration reform, Gottliebsen on the battle for control of OHS laws and Bartholomeusz on credit markets, China and FIRB.
Want access to our latest research and new buy ideas?
Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.Sign up for free